Deliberate Dysentery
Codon
JANUARY 21, 2024
We wouldn't do a challenge trial for Ebola, because the disease is extremely severe, and there are currently no licensed treatments or vaccines. And so, there was a lot of debate about that back in 2017 and 2018 , when they were considering these trials in the first place. So that's a drawback. 5 AP: Who decides your risk level?
Let's personalize your content